T. Rowe Price Investment Management, Inc. Applied Therapeutics Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 207,550 shares of APLT stock, worth $182,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207,550Holding current value
$182,644% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$9.28 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$8.72 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$8.65 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$7.04 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$5.98 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $42.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...